Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases

Myostatin (MSTN) is a negative regulator of skeletal muscle mass. Strategies to block myostatin signaling pathway have been extensively pursued to increase muscle mass in various disease settings including muscular dystrophy. Here, we report a new class of reagents based on transcription activator-l...

Full description

Bibliographic Details
Main Authors: Li Xu, Piming Zhao, Andrew Mariano, Renzhi Han
Format: Article
Language:English
Published: Elsevier 2013-01-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253116301706
_version_ 1819153453499285504
author Li Xu
Piming Zhao
Andrew Mariano
Renzhi Han
author_facet Li Xu
Piming Zhao
Andrew Mariano
Renzhi Han
author_sort Li Xu
collection DOAJ
description Myostatin (MSTN) is a negative regulator of skeletal muscle mass. Strategies to block myostatin signaling pathway have been extensively pursued to increase muscle mass in various disease settings including muscular dystrophy. Here, we report a new class of reagents based on transcription activator-like effector nucleases (TALENs) to disrupt myostatin expression at the genome level. We designed a pair of MSTN TALENs to target a highly conserved sequence in the coding region of the myostatin gene. We demonstrate that codelivery of these MSTN TALENs induce highly specific and efficient gene disruption in a variety of human, cattle, and mouse cells. Based upon sequence analysis, this pair of TALENs is expected to be functional in many other mammalian species. Moreover, we demonstrate that these MSTN TALENs can facilitate targeted integration of a mCherry expression cassette or a larger muscular dystrophy gene (dysferlin) expression cassette into the MSTN locus in mouse or human cells. Therefore, targeted editing of the myostatin gene using our highly specific and efficient TALEN pair would facilitate cell engineering, allowing potential use in translational research for cell-based therapy.
first_indexed 2024-12-22T15:05:26Z
format Article
id doaj.art-e18a4292b694489d8f024574dfca076a
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-22T15:05:26Z
publishDate 2013-01-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-e18a4292b694489d8f024574dfca076a2022-12-21T18:22:00ZengElsevierMolecular Therapy: Nucleic Acids2162-25312013-01-012C10.1038/mtna.2013.39Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE NucleasesLi Xu0Piming Zhao1Andrew Mariano2Renzhi Han3Department of Cell and Molecular Physiology, Loyola University Chicago Health Science Division, Maywood, IllinoisDepartment of Cell and Molecular Physiology, Loyola University Chicago Health Science Division, Maywood, IllinoisDepartment of Cell and Molecular Physiology, Loyola University Chicago Health Science Division, Maywood, IllinoisDepartment of Cell and Molecular Physiology, Loyola University Chicago Health Science Division, Maywood, IllinoisMyostatin (MSTN) is a negative regulator of skeletal muscle mass. Strategies to block myostatin signaling pathway have been extensively pursued to increase muscle mass in various disease settings including muscular dystrophy. Here, we report a new class of reagents based on transcription activator-like effector nucleases (TALENs) to disrupt myostatin expression at the genome level. We designed a pair of MSTN TALENs to target a highly conserved sequence in the coding region of the myostatin gene. We demonstrate that codelivery of these MSTN TALENs induce highly specific and efficient gene disruption in a variety of human, cattle, and mouse cells. Based upon sequence analysis, this pair of TALENs is expected to be functional in many other mammalian species. Moreover, we demonstrate that these MSTN TALENs can facilitate targeted integration of a mCherry expression cassette or a larger muscular dystrophy gene (dysferlin) expression cassette into the MSTN locus in mouse or human cells. Therefore, targeted editing of the myostatin gene using our highly specific and efficient TALEN pair would facilitate cell engineering, allowing potential use in translational research for cell-based therapy.http://www.sciencedirect.com/science/article/pii/S2162253116301706dysferlingene editingmyostatinTALEN
spellingShingle Li Xu
Piming Zhao
Andrew Mariano
Renzhi Han
Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases
Molecular Therapy: Nucleic Acids
dysferlin
gene editing
myostatin
TALEN
title Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases
title_full Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases
title_fullStr Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases
title_full_unstemmed Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases
title_short Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases
title_sort targeted myostatin gene editing in multiple mammalian species directed by a single pair of tale nucleases
topic dysferlin
gene editing
myostatin
TALEN
url http://www.sciencedirect.com/science/article/pii/S2162253116301706
work_keys_str_mv AT lixu targetedmyostatingeneeditinginmultiplemammalianspeciesdirectedbyasinglepairoftalenucleases
AT pimingzhao targetedmyostatingeneeditinginmultiplemammalianspeciesdirectedbyasinglepairoftalenucleases
AT andrewmariano targetedmyostatingeneeditinginmultiplemammalianspeciesdirectedbyasinglepairoftalenucleases
AT renzhihan targetedmyostatingeneeditinginmultiplemammalianspeciesdirectedbyasinglepairoftalenucleases